Table 1. Demographics of the study cohort.

	(range or % of total)
Patients	76 (100)
Median age, years	64 (41–77)
Median PSA at diagnosis, ng/ml	5.6 (1.1–17.4)
Median free PSA at diagnosis, %	12.0 (6.0–36.0)
Median follow-up time, months	66 (11–112)
Median time between mpMRIs, months	24 (4–73)
Histologic Bx upgrading, number of patients	15 (20)
of which GS 3+4 = 7	12 (16)
of which GS 4+3 = 7	3 (4)
Median time between diagnostic and
latest Bx (GS = 6), months, n = 61	48 (11–86)
upgrading Bx (GS >6), n = 15	41 (12–85)

Abbreviations: PSA = Prostate Specific Antigen; Bx = Prostate Biopsy; GS = Gleason Score, mpMRI = Multiparametric Magnetic Resonance Imaging.